文献速递消化道肿瘤放疗放疗物理与技术

磁共振引导放疗影像数据的差值影像组学分析可实现胰腺癌治疗反应预测

Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data can enable treatment response prediction in pancreatic cancer.
PubMed 文献 · Radiat Oncol · 2021-12-15

本研究在26例接受5次50 Gy磁共振引导立体定向体部放疗的局部晚期和临界可切除胰腺导管腺癌患者中,从0.35T磁共振扫描的肿瘤大体体积提取73个直方图和纹理影像组学特征,分析首次与末次分次扫描特征比值与无进展生存期的相关性。结果显示治疗期间直方图偏度变化与无进展生存期显著相关(p=0.005,HR=2.75),并识别出对勾画变异稳健的特征,为磁共振引导放疗的早期疗效预测提供了概念验证。

要点

  • 将图像强度线性归一化至肾脏中位值可提高特征量化的可重复性。
  • 治疗期间直方图偏度变化与无进展生存期显著相关(p=0.005,HR=2.75)。
  • 稳定性分析显示特征对感兴趣区勾画的敏感性分布广泛,并识别出对勾画变异稳健的特征。

核心结论

  • 本研究为磁共振引导放疗中利用定量图像分析预测治疗反应提供了概念验证,并提供了可用于未来磁共振引导放疗影像组学研究的分析流程。

研究设计与样本

  • 研究纳入26例接受5次50 Gy放疗的局部晚期和临界可切除胰腺导管腺癌患者,从0.35T磁共振引导立体定向体部放疗扫描的肿瘤大体体积中提取73个直方图和纹理影像组学特征。
  • 分析首次(F1)与末次(F5)分次扫描之间的特征比值与无进展生存期的相关性,并通过感兴趣区扰动评估特征稳定性。

主要发现

  • 将图像强度线性归一化至肾脏中位值可提高特征量化的可重复性。
  • 治疗期间直方图偏度变化与无进展生存期显著相关(p=0.005,HR=2.75),可能作为放疗反应的预测生物标志物。
  • 稳定性分析显示特征对感兴趣区勾画的敏感性分布广泛,并识别出对勾画变异稳健的特征。

关键数值与推荐

  • 73个直方图和纹理影像组学特征从26例患者的肿瘤大体体积中提取。
  • 放疗方案为50 Gy分5次。
  • 直方图偏度变化与无进展生存期关联的统计量为p=0.005,HR=2.75。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Magnetic Resonance Image guided Stereotactic body radiotherapy (MRgRT) is an emerging technology that is increasingly used in treatment of visceral cancers, such as pancreatic adenocarcinoma (PDAC). Given the variable response rates and short progression times of PDAC, there is an unmet clinical need for a method to assess early RT response that may allow better prescription personalization. We hypothesize that quantitative image feature analysis (radiomics) of the longitudinal MR scans acquired before and during MRgRT may be used to extract information related to early treatment response. METHODS: Histogram and texture radiomic features (n = 73) were extracted from the Gross Tumor Volume (GTV) in 0.35T MRgRT scans of 26 locally advanced and borderline resectable PDAC patients treated with 50 Gy RT in 5 fractions. Feature ratios between first (F1) and last (F5) fraction scan were correlated with progression free survival (PFS). Feature stability was assessed through region of interest (ROI) perturbation. RESULTS: Linear normalization of image intensity to median kidney value showed improved reproducibility of feature quantification. Histogram skewness change during treatment showed significant association with PFS (p = 0.005, HR = 2.75), offering a potential predictive biomarker of RT response. Stability analyses revealed a wide distribution of feature sensitivities to ROI delineation and was able to identify features that were robust to variability in contouring. CONCLUSIONS: This study presents a proof-of-concept for the use of quantitative image analysis in MRgRT for treatment response prediction and providing an analysis pipeline that can be utilized in future MRgRT radiomic studies.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Tomaszewski MR, Latifi K, Boyer E, et al. Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data can enable treatment response prediction in pancreatic cancer. Radiat Oncol. 2021. PMID: 34911546. doi:10.1186/s13014-021-01957-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。